Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Applying flow cytometry-based isolation of platelet-derived microparticles to banked human plasma for cellular studies.
Journal: The Journal of pathology
Published: December 12, 2025
Platelet-derived S100A9 contributes to endotheliopathy in alcohol-associated hepatitis.
Journal: JCI insight
Published: October 09, 2025
Hepatic Arterial Flow-Induced Portal Tract Fibrosis in Portal Hypertension: The Role of VCAM-1 and Osteopontin-Expressing Macrophages.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis Progression.
Journal: bioRxiv : the preprint server for biology
Published: January 27, 2025
Hepatic Arterial Flow-Induced Portal Tract Fibrosis in Portal Hypertension: The Role of VCAM-1 and Osteopontin-Expressing Macrophages.
Journal: Cellular and molecular gastroenterology and hepatology
Published: January 26, 2025
Interleukin-7-based identification of liver lymphatic endothelial cells reveals their unique structural features.
Journal: JHEP reports : innovation in hepatology
Published: November 19, 2023
An optimized visualization and quantitative protocol for in-depth evaluation of lymphatic vessel architecture in the liver.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: August 22, 2023
Portal Hypertension in Alcohol-Associated Hepatitis.
Journal: Current hepatology reports
Published: February 23, 2023
The Sympathetic Nervous System Promotes Hepatic Lymphangiogenesis, which Is Protective Against Liver Fibrosis.
Journal: The American journal of pathology
Published: January 29, 2023
The evolving role of liver sinusoidal endothelial cells in liver health and disease.
Journal: Hepatology (Baltimore, Md.)
Published: August 01, 2022
Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis.
Journal: Hepatology communications
Published: June 11, 2021
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 22, 2021
Last Updated: 09/26/2026